Investigation of polymorphism in the MDR1 gene and antidepressant-induced mania

Pharmacogenomics Journal

Volumn 3, Issue 5, 2003, Pages 297-299

  De Luca, V ^a   Mundo, E ^a,b   Trakalo, J ^a   Wong, G W H ^a   Kennedy, James L ^a  

^a UNIVERSITY OF TORONTO   (Canada)

^b UNIVERSITY OF MILAN   (Italy)

Author keywords

ABCB1; Antidepressant; Bipolar disorder; Mania; MDR1; Polymorphism

Indexed keywords

ANTIDEPRESSANT AGENT; DNA; FEXOFENADINE; FLUOXETINE; FLUVOXAMINE; GLYCOPROTEIN P; IMIPRAMINE; MOCLOBEMIDE; MULTIDRUG RESISTANCE PROTEIN 1; NEFAZODONE; NORTRIPTYLINE; PAROXETINE; SEROTONIN AGONIST; SERTRALINE; VENLAFAXINE;

ALLELE; ARTICLE; BIPOLAR DEPRESSION; BLOOD BRAIN BARRIER; CONTROLLED STUDY; DNA ISOLATION; DRUG RESPONSE; DRUG TRANSPORT; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; HYPOMANIA; MAJOR CLINICAL STUDY; MANIA; POLYMERASE CHAIN REACTION; PREDICTION; PRIORITY JOURNAL; STATISTICAL ANALYSIS;

ANTIDEPRESSIVE AGENTS; BIPOLAR DISORDER; CHI-SQUARE DISTRIBUTION; GENE FREQUENCY; GENES, MDR; GENOTYPE; HUMANS; POLYMORPHISM, GENETIC;

EID: 0242575121     PISSN: 1470269X     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.tpj.6500196     Document Type: Article

References (24)

1. Ambudkar SV, Dey S, Hrycyna CA, Ramachandra M, Pastan I, Gottesman MM. Biochemical, cellular, and pharmacological aspects of the multidrug transporter. Annu Rev Pharmacol Toxicol 1998; 39: 361-398.
2. Uhr M, Steckler T, Yassouridis A, Holsboer F. Penetration of amitriptyline, but not of aluoxetine, into brain is enhanced in mice with blood-brain barrier deficiency due to mdr1a P-glycoprotein gene disruption. Neuropsychopharmacology 2000; 22: 380-387.
3. McGuffin P, Katz R. The genetics of depression and manic-depressive disorder. Br J Psychiatry 1989; 155: 294-304.
4. Gershon ES. Genetics. In: Goodwin FK, Jamison KR (eds). Manic-Depressive Illness. Oxford University Press: New York, NY 1990; pp 373-401.
5. Nurnberger Jr JI, Gershon ES. Genetics. In: Paykel ES (ed). Handbook of Affective Disorders. Churchill Livingstone Inc.: New York, NY 1992; pp 131-148.
6. Hoffmeyer S, Burk O, Richter OV, Arnold HP, Brockmoller J, Johne A et al. Functional polymorphisms of the human multidrug-resistance gene: multiple sequence variations and correlation of one allele with P-glycoprotein expression and activity in vivo. Proc Natl Acad Sci USA 2000; 97: 3473-3478.
7. Verstuyft C, Schwab M, Schaeffeler E, Kerb R, Brinkmann U, Jaillon P et al. Digoxin pharmacokinetics and MDR1 genetic polymorphisms. Eur J Clin Pharmacol 2003; 58: 809-812.
8. Kim RB, Leake BF, Choo EF, Dresser GK, Kubba SV, Schwartz UI et al. Identification of functionally variant MDR1 alleles among European Americans and Americans. Clin Pharmacol Ther 2001; 70: 189-199.
9. Drescher S, Schaeffeler E, Hitzl M, Hofmann U, Schwab M, Brinkmann U et al. MDR1 gene polymorphisms and disposition of the P-glycoprotein substrate fexofenadine. Br J Clin Pharmacol 2002; 53: 526-534.
10. Hitzl M, Drescher S, van der Kuip H, Schaffeler E, Fischer J, Schwab M et al. The C3435T mutation in the human MDR1 gene is associated with altered efflux of the P-glycoprotein substrate rhodamine 123 from CD56(+) natural killer cells. Pharmacogenetics 2001; 11: 293-298.
11. Morita Y, Sakaeda T, Horinouchi M, Nakamura T, Kuroda K, Miki I et al. MDR1 genotype-related duodenal absorption rate of digoxin in healthy Japanese subjects. Pharm Res 2003; 20: 552-556.
12. Roberts R, Joyce P, Mulder R, Begg E, Kennedy MA. A common P-glycoprotein polymorphism is associated with nortriptyline-induced postural hypotension in patients treated with major depression. Pharmacogenomics J 2002; 2: 191-196.
13. Wehr TA, Goodwin FK. Can antidepressants cause mania and worsen the course of affective illness? Am J Psychiatry 1987; 144: 1403-1411.
14. Altshuler LL, Post RM, Leverich GS, Mikalauskas K, Rosoff A, Ackerman L. Antidepressant-induced mania and cycle acceleration: a controversy revisited. Am J Psychiatry 1995; 152: 1130-1138.
15. Howland RH. Induction of mania with serotonin reuptake inhibitors. J Clin Psychopharmacol 1996; 16: 425-427.
16. Boerlin HL, Gitlin MJ, Zoellner LA, Hammen CL. Bipolar depression and antidepressant-induced mania: a naturalistic study. J Clin Psychiatry 1998; 59: 374-379.
17. Angst J. Switch from depression to mania: a record survey over decades between 1920 and 1982. Psychopathology 1985; 18: 140-154.
18. Mundo E, Walker M, Cate T, Macciardi F, Kennedy JL. The role of serotonin transporter gene in antidepressant-induced mania in bipolars. Arch Gen Psychiatry 2000; 47(Suppl): 135S.
19. Lahiri DK, Nurnberger JI. A rapid no-enzymatic method for the preparation of HMW DNA from blood for RFLP analysis. Nucleic Acids Res 1991; 19: 5444.
20. Tang K, Ngoi S, Gwee P, Chua JMZ, Lee EJD, Chong SS et al. Distinct haplotype profiles and strong linkage disequilibrium at the MDR1 multidrug transporter gene locus in three ethnic Asian populations. Pharmacogenetics 2002; 12: 437-450.
21. Coryell W, Endicott J, Keller M. Rapid cycling affective disorder: demographics, diagnosis, family history and course. Arch Gen Psychiatry 1992; 49: 126-131.
22. Mahar Doan KM, Humphreys JE, Webster LO, Wring SA, Shampine LJ, Serabjit-Singh CJ et al. Passive permeability and P-glycoprotein-mediated efflux differentiate central nervous system (CNS) and non-CNS marketed drugs. J Pharmacol Exp Therap 2002; 303: 1029-1037.
23. Uhr M, Grauer MT, Holsboer F. Differential enhancement of anti-depressant penetration into the brain in mice with abcb1 ab (mdr1ab) P-glycoprotein gene disruption. Biol Psychiatry, Print copy in press (original) published online May 3, 2003, at http://www-east.elsevier.com/bps/prepub.htm).
24. Uhr M, Grauer MT. abcb1ab P-glycoprotein is involved in the uptake of citalopram and trimipramine into the brain of mice. J Psychiatr Res 2003; 37: 179-185.